80 related articles for article (PubMed ID: 8108317)
21. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
Otto D; Unsicker K
J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
[TBL] [Abstract][Full Text] [Related]
22. Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
Serra PA; Esposito G; Enrico P; Mura MA; Migheli R; Delogu MR; Miele M; Desole MS; Grella G; Miele E
Br J Pharmacol; 2000 Jun; 130(4):937-45. PubMed ID: 10864903
[TBL] [Abstract][Full Text] [Related]
23. Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.
Pardo B; Mena MA; Casarejos MJ; Paíno CL; De Yébenes JG
Brain Res; 1995 Jun; 682(1-2):133-43. PubMed ID: 7552304
[TBL] [Abstract][Full Text] [Related]
24. 3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
Reches A; Fahn S
Ann Neurol; 1982 Sep; 12(3):267-71. PubMed ID: 7137962
[TBL] [Abstract][Full Text] [Related]
25. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
Pestana M; Soares-da-Silva P
Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
[TBL] [Abstract][Full Text] [Related]
26. Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC.
Cannazza G; Di Stefano A; Mosciatti B; Braghiroli D; Baraldi M; Pinnen F; Sozio P; Benatti C; Parenti C
J Pharm Biomed Anal; 2005 Jan; 36(5):1079-84. PubMed ID: 15620535
[TBL] [Abstract][Full Text] [Related]
27. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
28. Neuronal-enriched cultures from embryonic rat ventral mesencephalon for pharmacological studies of dopamine neurons.
Pardo B; Paíno CL; Casarejos MJ; Mena MA
Brain Res Brain Res Protoc; 1997 May; 1(2):127-32. PubMed ID: 9385075
[TBL] [Abstract][Full Text] [Related]
29. Different developmental potentials of diencephalic and mesencephalic dopaminergic neurons in vitro.
Engele J; Pilgrim C; Kirsch M; Reisert I
Brain Res; 1989 Mar; 483(1):98-109. PubMed ID: 2565148
[TBL] [Abstract][Full Text] [Related]
30. Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum.
Mertens B; Vanderheyden P; Michotte Y; Sarre S
Neuropharmacology; 2010 Jun; 58(7):1038-44. PubMed ID: 20097214
[TBL] [Abstract][Full Text] [Related]
31. Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures.
Sanchez-Ramos J; Facca A; Basit A; Song S
Exp Neurol; 1998 Apr; 150(2):263-71. PubMed ID: 9527896
[TBL] [Abstract][Full Text] [Related]
32. Outflow of dopamine and noradrenaline originating from L-dopa and L-threo-DOPS in rat renal tissues.
Pestana M; Soares-Da-Silva P
Gen Pharmacol; 1994 Sep; 25(5):879-85. PubMed ID: 7835631
[TBL] [Abstract][Full Text] [Related]
33. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
Cummings J; Matheson LM; Smyth JF
J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
[TBL] [Abstract][Full Text] [Related]
34. Dopamine turnover in the mediobasal hypothalamus in rat fetuses.
Melnikova V; Orosco M; Calas A; Sapronova A; Gainetdinov R; Delhaye-Bouchaud N; Nicolaidis S; Rayevsky K; Ugrumov M
Neuroscience; 1999 Mar; 89(1):235-41. PubMed ID: 10051232
[TBL] [Abstract][Full Text] [Related]
35. Identification of L-dopa immunoreactivity in some neurons in the human mesencephalic region: a novel dopa neuron group?
Komori K; Uesaka S; Yamaoka H; Fujita K; Yamaoka K; Naitoh H; Kuroda M; Karasawa N; Ito T; Kasahara Y
Neurosci Lett; 1993 Jul; 157(1):13-6. PubMed ID: 8233022
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive dopamine determination by reversed phase HPLC in the medium of free-floating roller tube cultures of rat fetal ventral mesencephalon: a tool to assess dopaminergic tissue prior to grafting.
Studer L; Psylla M; Bühler B; Evtouchenko L; Vouga CM; Leenders KL; Seiler RW; Spenger C
Brain Res Bull; 1996; 41(3):143-50. PubMed ID: 8886383
[TBL] [Abstract][Full Text] [Related]
37. Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues.
Yu PH; Bailey BA; Durden DA; Boulton AA
Biochem Pharmacol; 1986 Mar; 35(6):1027-36. PubMed ID: 3954792
[TBL] [Abstract][Full Text] [Related]
38. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells.
Prochiantz A; di Porzio U; Kato A; Berger B; Glowinski J
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5387-91. PubMed ID: 291955
[TBL] [Abstract][Full Text] [Related]
39. L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress.
Han SK; Mytilineou C; Cohen G
J Neurochem; 1996 Feb; 66(2):501-10. PubMed ID: 8592119
[TBL] [Abstract][Full Text] [Related]
40. Early hypoxia modulates the phenotype of dopaminergic cells in rat di- and mesencephalic cell cultures and induces a higher vulnerability of non-dopaminergic neurons to a second hypoxic exposure.
Husemann B; Andreeva N; Gao J; Heldt J; Andersson K; Gross J
Neurosci Lett; 1999 Nov; 275(1):53-6. PubMed ID: 10554983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
